Literature DB >> 11040083

Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids.

A M Joussen1, K Rohrschneider, J Reichling, B Kirchhof, F E Kruse.   

Abstract

The purpose of this study was to investigate the use of dietary isoflavonoids and flavonoids for the treatment of ocular neovascularization. Corneal blood vessels were induced by intrastromal implantation of pellets containing bFGF. Isoflavonoids and flavonoids (Genistein, Fisetin and Luteolin) were dissolved in a microemulsion to increase bioavailability and applied topically in concentrations between 0.5 and 1 ng ml(-1). Corneal neovascularization was quantified under the microscope. In comparison to control eyes, all three substances significantly inhibited corneal neovascularization (P < or = 0.05). Fisetin had the strongest effect followed by Genistein and Luteolin. No significant topical side effects were observed. We concluded that the isoflavonoid Genistein and two structurally related flavonoids are potent inhibitors of corneal angiogenesis in vivo. The wide distribution of the flavonoids in the plant kingdom together with the presented results suggests that flavonoids may contribute to the preventive effect of a plant-based diet on neovascular disease of the eye. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040083     DOI: 10.1006/exer.2000.0900

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  11 in total

Review 1.  Phenoxodiol: isoflavone analog with antineoplastic activity.

Authors:  Toni K Choueiri; Robert Wesolowski; Tarek M Mekhail
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

2.  Inhibition of corneal angiogenesis by ascorbic acid in the rat model.

Authors:  Gholam A Peyman; Muhamet Kivilcim; Ana Munoz Morales; John T DellaCroce; Mandi D Conway
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-21       Impact factor: 3.117

3.  Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.

Authors:  Yasmine S Touil; Johanne Seguin; Daniel Scherman; Guy G Chabot
Journal:  Cancer Chemother Pharmacol       Date:  2010-11-11       Impact factor: 3.333

Review 4.  Potential of the bioflavonoids in the prevention/treatment of ocular disorders.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  J Pharm Pharmacol       Date:  2010-08       Impact factor: 3.765

Review 5.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

6.  Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization.

Authors:  Yasmine S Touil; Arlette Fellous; Daniel Scherman; Guy G Chabot
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

7.  Androgen deprivation by flutamide modulates uPAR, MMP-9 expressions, lipid profile, and oxidative stress: amelioration by daidzein.

Authors:  Abdul Lateef; Abdul Quaiyoom Khan; Mir Tahir; Rehan Khan; Muneeb U Rehman; Farrah Ali; Oday O Hamiza; Sarwat Sultana
Journal:  Mol Cell Biochem       Date:  2012-11-08       Impact factor: 3.396

8.  Anti-cancer potential of flavonoids: recent trends and future perspectives.

Authors:  Priya Batra; Anil K Sharma
Journal:  3 Biotech       Date:  2013-02-12       Impact factor: 2.406

Review 9.  Integrating traditional medicine into modern inflammatory diseases care: multitargeting by Rhus verniciflua Stokes.

Authors:  Ji Hye Kim; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2014-06-12       Impact factor: 4.711

10.  Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis.

Authors:  Mai Khater; Francesca Greco; Helen M I Osborn
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.